Bryan Cox

发表

Anti‐HIV Small‐Molecule Binding in the Peptide Subpocket of the CXCR4:CVX15 Crystal Structure

J. Snyder, D. Liotta, L. Wilson, 2014, Chembiochem : a European journal of chemical biology.

Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses

A. Yueh, R. Schinazi, M. Teixeira, 2019, Antimicrobial Agents and Chemotherapy.

Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.

R. Schinazi, Bryan Cox, F. Amblard, 2017, Bioorganic & medicinal chemistry letters.

Structure, energetics, and dynamics of binding coactivator peptide to the human retinoid X receptor α ligand binding domain complex with 9-cis-retinoic acid.

Craig D. Smith, M. Renfrow, Bryan Cox, 2011, Biochemistry.

Synthesis and antiviral evaluation of novel peptidomimetics as norovirus protease inhibitors.

R. Schinazi, P. Liu, L. Kovari, 2018, Bioorganic & medicinal chemistry letters.

The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor

Eric J Miller, Eric J. Miller, D. Liotta, 2018, Molecular Pharmacology.

In silico design of a novel nucleotide antiviral agent by free energy perturbation

R. Schinazi, Bryan Cox, K. Verma, 2022, Chemical biology & drug design.

Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor α Ligand Binding Domain*

M. J. Chalmers, P. Griffin, Craig D. Smith, 2013, The Journal of Biological Chemistry.

Structure, Energetics and Dynamics of Binding Coactivator Peptide to Human Retinoid X Receptor Alpha Ligand Binding Domain Complex with 9-cis-Retinoic Acid

M. Renfrow, Bryan Cox, G. Xia, 2012 .

Agonist of RORA Attenuates Non-Alcoholic Fatty Liver Progression in Mice via Upregulation of microRNA 122.

R. Schinazi, H. Giladi, E. Galun, 2020, Gastroenterology.

Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor.

J. Snyder, D. Liotta, A. Tebben, 2018, ACS medicinal chemistry letters.

Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents.

R. Schinazi, Ozkan Sari, Bryan Cox, 2020, Bioorganic & medicinal chemistry.

Oats Lower Age-Related Systemic Chronic Inflammation (iAge) in Adults at Risk for Cardiovascular Disease

Kevin L. Schneider, D. Furman, D. Vigerust, 2022, Nutrients.

Jak Inhibitors Modulate Production of Replication-Competent Zika Virus in Human Hofbauer, Trophoblasts, and Neuroblastoma cells

R. Schinazi, Erica L Johnson, M. Suthar, 2017, Pathogens & immunity.

Novel and potent HBV capsid modulator reduces HBeAg and cccDNA in core site directed T109I mutant in HepNTCP cells

R. Schinazi, S. Ono, Bryan Cox, 2018 .

Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase.

J. Snyder, V. Bond, D. Liotta, 2015, ACS medicinal chemistry letters.

Conformational Analysis of Retinoic Acids: Effects of Steric Interactions on Nonplanar Conjugated Polyenes.

T. Hamilton, Bryan Cox, D. Muccio, 2013, Computational & theoretical chemistry.

Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.

D. Watkins, G. Saade, M. Garcia-Blanco, 2017, Antiviral research.

7-Deaza-7-Fluoro-2'-C-Methyladenosine Inhibits Zika virus Infection and Viral-induced Neuroinflammation.

R. Schinazi, M. Teixeira, S. Rehen, 2020, Antiviral research.

The Mechanism of Action of Hepatitis B Virus Capsid Assembly Modulators Can Be Predicted from Binding to Early Assembly Intermediates.

C. Chipot, R. Schinazi, J. Gumbart, 2022, Journal of medicinal chemistry.

Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses In Vitro and in Humanized Mice

R. Schinazi, J. D. Di Santo, H. de Rocquigny, 2019, Antimicrobial Agents and Chemotherapy.

Synthesis and antiviral evaluation of 2',2',3',3'-tetrafluoro nucleoside analogs.

R. Schinazi, Ozkan Sari, Bryan Cox, 2017, Tetrahedron letters.

Autophagy and Apoptosis in Hepatocellular Carcinoma Induced by EF25-(GSH)2: A Novel Curcumin Analog

J. Snyder, Dahai Liu, H. Fu, 2014, PloS one.

Innate, non-cytolytic CD8+ T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription

G. Silvestri, M. Paiardini, G. Tharp, 2020, PLoS pathogens.

Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals

R. Ptak, M. Busch, S. Deeks, 2019, PLoS pathogens.

A CXCL8 receptor antagonist based on the structure of N-acetyl-proline-glycine-proline.

M. Hardison, J. Blalock, B. Noerager, 2011, European journal of pharmacology.

Novel influenza polymerase PB2 inhibitors for the treatment of influenza A infection.

R. Schinazi, K. Zandi, Bryan Cox, 2019, Bioorganic & medicinal chemistry letters.

Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector.

R. Schinazi, Ozkan Sari, Bryan Cox, 2017, European journal of medicinal chemistry.

Structural analysis of CXCR4 - Antagonist interactions using saturation-transfer double-difference NMR.

J. Snyder, A. Mehta, D. Liotta, 2015, Biochemical and biophysical research communications.

Predicting Zika virus structural biology: Challenges and opportunities for intervention

Richard A. Stanton, R. Schinazi, Bryan Cox, 2015, Antiviral chemistry & chemotherapy.

Erratum for Amblard et al., “Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses In Vitro and in Humanized Mice”

R. Schinazi, J. D. Di Santo, H. de Rocquigny, 2020, Antimicrobial Agents and Chemotherapy.

FRI-157-Novel HBV capsid assembly modulator inhibits pregenomic RNA encapsidation by accelerating capsid assembly kinetics and disrupting core protein dephosphorylation

R. Schinazi, S. Ono, Bryan Cox, 2019, Journal of Hepatology.

Mechanism of action of HBV capsid assembly modulators predicted from binding to early assembly intermediates

C. Chipot, R. Schinazi, J. Gumbart, 2020, bioRxiv.

Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.

D. Watkins, G. Saade, M. Garcia-Blanco, 2017, Antiviral research.